Quinethazone: Difference between revisions
m Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +) |
No edit summary |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{drugbox | | {{drugbox | | ||
| IUPAC_name = 7-chloro-2-ethyl-4-oxo-1,2,3,4-tetrahydroquinazoline-<br>6-sulfonamide | | IUPAC_name = 7-chloro-2-ethyl-4-oxo-1,2,3,4-tetrahydroquinazoline-<br>6-sulfonamide | ||
| Line 24: | Line 23: | ||
| routes_of_administration = Oral | | routes_of_administration = Oral | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | {{CMG}} | ||
==Overview== | |||
'''Quinethazone''' ([[International Nonproprietary Name|INN]], brand name '''Hydromox''') is a [[thiazide]] [[diuretic]] used to treat [[hypertension]]. Common side effects include [[dizziness]], dry mouth, [[nausea]], and [[hypokalemia|low potassium]] levels. | '''Quinethazone''' ([[International Nonproprietary Name|INN]], brand name '''Hydromox''') is a [[thiazide]] [[diuretic]] used to treat [[hypertension]]. Common side effects include [[dizziness]], dry mouth, [[nausea]], and [[hypokalemia|low potassium]] levels. | ||
==References== | |||
{{reflist|2}} | |||
{{Antihypertensives and diuretics}} | {{Antihypertensives and diuretics}} | ||
[[Category: | ==References== | ||
[[Category:Drugs]] | {{reflist|2}} | ||
[[Category:Diuretics]] | |||
[[Category:Sulfonamides]] | |||
[[Category:Cardiovascular Drugs]] | |||
[[Category:Drug]] | |||
Latest revision as of 01:14, 25 July 2014
 | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C10H12ClN3O3S |
| Molar mass | 289.739 g/mol |
|
WikiDoc Resources for Quinethazone |
|
Articles |
|---|
|
Most recent articles on Quinethazone Most cited articles on Quinethazone |
|
Media |
|
Powerpoint slides on Quinethazone |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Quinethazone at Clinical Trials.gov Clinical Trials on Quinethazone at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Quinethazone
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Quinethazone Discussion groups on Quinethazone Patient Handouts on Quinethazone Directions to Hospitals Treating Quinethazone Risk calculators and risk factors for Quinethazone
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Quinethazone |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Quinethazone (INN, brand name Hydromox) is a thiazide diuretic used to treat hypertension. Common side effects include dizziness, dry mouth, nausea, and low potassium levels.
References
References
- Pages with script errors
- Drugs with non-standard legal status
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Diuretics
- Sulfonamides
- Cardiovascular Drugs
- Drug